Shineyo Medical Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 86

Employees

  • Latest Deal Type
  • Series A3

  • Investors
  • 15

Shineyo Medical General Information

Description

Developer of medical devices designed to advance the treatment of cardiac electrophysiology and peripheral vascular conditions. The company offers self-developed active medical devices, vascular intervention catheters, and biomedical material technologies, enabling healthcare providers to offer innovative treatments for atrial fibrillation, varicose veins, and pulmonary embolism, while filling a domestic gap in medical device innovation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 620, Building 1, No. 351, Guoshoujing Road
  • Pudong New District
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Corporate Office
  • Room 620, Building 1, No. 351, Guoshoujing Road
  • Pudong New District
  • Shanghai, 201203
  • China
+86 021

Shineyo Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shineyo Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A3) 02-Apr-2025 Completed Clinical Trials - General
5. Early Stage VC (Series AAA) 05-Nov-2024 Completed Clinical Trials - General
4. Early Stage VC (Series A1) 12-Aug-2024 Completed Clinical Trials - General
3. Early Stage VC (Series A) 21-Jun-2022 Completed Clinical Trials - General
2. Early Stage VC 01-Jul-2021 Completed Startup
1. Seed Round 01-Dec-2020 Completed Startup
To view Shineyo Medical’s complete valuation and funding history, request access »

Shineyo Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shineyo Medical Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangzhou Baiyun Financial Technology Holding Group Government Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Guangzhou Jinkong Fund Asset Manager Minority
Jinxin Capital Investment Management Corporation Venture Capital Minority
Suzhou Asset Management Asset Manager Minority
You’re viewing 5 of 15 investors. Get the full list »

Shineyo Medical FAQs

  • When was Shineyo Medical founded?

    Shineyo Medical was founded in 2020.

  • Where is Shineyo Medical headquartered?

    Shineyo Medical is headquartered in Shanghai, China.

  • What is the size of Shineyo Medical?

    Shineyo Medical has 86 total employees.

  • What industry is Shineyo Medical in?

    Shineyo Medical’s primary industry is Surgical Devices.

  • Is Shineyo Medical a private or public company?

    Shineyo Medical is a Private company.

  • What is Shineyo Medical’s current revenue?

    The current revenue for Shineyo Medical is .

  • How much funding has Shineyo Medical raised over time?

    Shineyo Medical has raised $33M.

  • Who are Shineyo Medical’s investors?

    Guangzhou Baiyun Financial Technology Holding Group, Shenzhen Yifeng Investment Management Enterprise, Guangzhou Jinkong Fund, Jinxin Capital Investment Management Corporation, and Suzhou Asset Management are 5 of 15 investors who have invested in Shineyo Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process